The company is scaling up manufacturing and commercial activities as it prepares to enter the U.S. market via the Food and Drug Administration’s de novo pathway.
SEATTLE--(BUSINESS WIRE)--Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, today announced the launch of its next generation technology for dried blood ...
The test includes the Weavr Velvet blood collection device, which separates the sample into its red blood cell and plasma components. Labcorp has launched the Diabetes Risk (HbA1c) at-home collection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results